Stiripentol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Stiripentol and local guidelines before prescribing.
Anticonvulsant
Mechanism
GABAergic anticonvulsant.
Uses
Dravet syndrome.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Drowsiness, reduced appetite, weight loss, ataxia.
Interactions
Strong CYP inhibitor raising clobazam and valproate.
Contraindications and cautions
Psychosis history
Monitoring
FBC, LFT
Pregnancy and breastfeeding
Specialist advice
Renal and hepatic impairment
Avoid in renal and hepatic impairment
Overdose and reversal
Supportive
Special advice
Used with clobazam and valproate.
More from the textbook: uses, cautions and other points
- Cannabidiol , stiripentol and fenfluramine (echocardiography) - specialist use in Dravet and Lennox–Gastaut syndromes.
Neurology: Anatomy, Physiology and Pharmacology - Dravet syndrome | SCN1A mutation; prolonged febrile and afebrile seizures from the first year, then developmental slowing. Avoid sodium channel blockers (carbamazepine, lamotrigine, phenytoin). Valproate, clobazam, stiripentol, fenfluramine, cannabidiol.
Paediatrics: Neurology, bones and joints in children
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Integrated paediatrics chapter (1 mention)